Netzealous LLC DBA - Compliance4All, Online
2018-10-22
Overview: The United Kingdom submitted its' notification on 29 March 2017 to
withdraw from the European Union. This means that unless a withdrawal
agreement establishes another date, all EU primary and secondary Laws
cease to apply to the UK from 30 March 2019 going forward.
Learning Objective: Upon completion of this course, attendees will be able to accurately
determine how Brexit will affect their operations and existing licensed Life
Science Products in the UK and EU It will allow companies to make plans on becoming compliant on "What is
Known" and to remain agile as the rest of the implications become clearer
Areas Covered in the Session: EU Regulatory and Legislative Structure [with and without the UK] Issued Laws: Directives vs. Regulations Impact on Filing Registrations with EMA in Q1 2019 Brexit Impact on License Holders Established in the UK What if my EU Authorized Representative is Located in the UK? What if the QPPV Resides in the UK? What if API Manufacturing is Located in the UK?
Who Will Benefit: Executive & General Management Legal Regulatory Affairs Quality Assurance Manufacturing /Distribution Clinical Research Product Development CROs Consultants
Event Fee: One Dial-in One Attendee Price: US$150.00
Contact Detail: Compliance4All DBA NetZealous, Phone: +1-800-447-9407 Email: support@compliance4All.com
|